Your browser doesn't support javascript.
loading
Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018).
He, Xingrui; Chen, Xiabin; Zhang, Hancheng; Xie, Tian; Ye, Xiang-Yang.
Afiliação
  • He X; a Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Hangzhou Normal University , Hangzhou , Zhejiang Province , China.
  • Chen X; b Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Hangzhou Normal University , Hangzhou , Zhejiang Province , China.
  • Zhang H; c Holistic Integrative Pharmacy Institutes (HIPI), School of Medicine , Hangzhou Normal University , Hangzhou, Zhejiang , China.
  • Xie T; a Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Hangzhou Normal University , Hangzhou , Zhejiang Province , China.
  • Ye XY; b Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Hangzhou Normal University , Hangzhou , Zhejiang Province , China.
Expert Opin Ther Pat ; 29(2): 137-149, 2019 02.
Article em En | MEDLINE | ID: mdl-30621465

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Inibidores de Proteínas Quinases / TYK2 Quinase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Expert Opin Ther Pat Assunto da revista: TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Inibidores de Proteínas Quinases / TYK2 Quinase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Expert Opin Ther Pat Assunto da revista: TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China